Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells

Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells

(2022) Razie Amraei et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TMEM16A channel upregulation in arterial smooth muscle cells produces vasoconstriction during diabetes

(2021) M. Dennis Leo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Lack of Evidence of ACE2 Expression and Replicative Infection by SARSCoV-2 in Human Endothelial Cells

(2021) Ian R. McCracken et al.   CIRCULATION

The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication

(2021) Madeline Loffredo et al.   Scientific Reports

Conserved and Novel Mouse CD8 T Cell Epitopes within SARS-CoV-2 Spike Receptor Binding Domain Protein Identified following Subunit Vaccination

(2021) Bennett J. Davenport et al.   JOURNAL OF IMMUNOLOGY

Post-acute COVID-19 syndrome

(2021) Ani Nalbandian et al.   NATURE MEDICINE

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

(2021) Robert W. Malone et al.   Frontiers in Pharmacology

Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants

(2021) Julian U. G. Wagner et al.   BASIC RESEARCH IN CARDIOLOGY

Long covid—mechanisms, risk factors, and management

(2021) Harry Crook et al.   BMJ-British Medical Journal

SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity

(2021) Somasundaram Raghavan et al.   Frontiers in Cardiovascular Medicine

Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis

(2021) Adriana Albini et al.   Frontiers in Immunology

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target

(2020) Haibo Zhang et al.   INTENSIVE CARE MEDICINE

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

(2020) Alexandra C. Walls et al.   CELL

The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications

(2020) Rami A. Ballout et al.   FASEB JOURNAL

Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

(2020) Daniel E. Freedberg et al.   GASTROENTEROLOGY

Endothelial cell infection and endotheliitis in COVID-19

(2020) Zsuzsanna Varga et al.   LANCET

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cell entry mechanisms of SARS-CoV-2

(2020) Jian Shang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

(2020) Yuan Huang et al.   ACTA PHARMACOLOGICA SINICA

Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2

(2020) Yu Zhao et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks

(2020) Markus Blaess et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

(2020) W. Joost Wiersinga et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Famotidine Against SARS-CoV2: A Hope or Hype?

(2020) Ritwik Ghosh et al.   MAYO CLINIC PROCEEDINGS

Impact of Famotidine Use on Clinical Outcomes of Hospitalized Patients With COVID-19

(2020) Jeffrey F. Mather et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

(2020) Eleni Gavriilaki et al.   CURRENT HYPERTENSION REPORTS

How COVID-19 can damage the brain

(2020) Michael Marshall   NATURE

Characteristics of SARS-CoV-2 and COVID-19

(2020) Ben Hu et al.   NATURE REVIEWS MICROBIOLOGY

COVID-19 – A vascular disease

(2020) Hasan K. Siddiqi et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Histamine release theory and roles of antihistamine in the treatment of cytokines storm of COVID-19

(2020) Omar Abdelhay Eldanasory et al.   Travel Medicine and Infectious Disease

Histamine receptors and COVID-19

(2020) Madeleine Ennis et al.   INFLAMMATION RESEARCH

Endothelial Damage in Acute Respiratory Distress Syndrome

(2020) Alice G. Vassiliou et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Identification of key signaling pathways induced by SARS‐CoV2 that underlie thrombosis and vascular injury in COVID‐19 patients

(2020) Anthony J. Maxwell et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

(2020) Elizabeth M. Rhea et al.   NATURE NEUROSCIENCE

Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses

(2020) Jonas Nascimento Conde et al.   mBio

Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein

(2020) Gerard J. Nuovo et al.   Annals of Diagnostic Pathology

SUMO1 modification of PKD2 channels regulates arterial contractility

(2019) Raquibul Hasan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Impaired Trafficking of β1 Subunits Inhibits BK Channels in Cerebral Arteries of Hypertensive Rats

(2018) M. Dennis Leo et al.   HYPERTENSION

Membrane depolarization activates BK channels through ROCK-mediated β1 subunit surface trafficking to limit vasoconstriction

(2017) M. Dennis Leo et al.   Science Signaling

Membrane depolarization activates BK channels through ROCK-mediated β1 subunit surface trafficking to limit vasoconstriction

(2017) M. Dennis Leo et al.   Science Signaling